FAP and central nervous system cancer: This FAP-targeted tracer, engineered with a quinolinium-based scaffold, exhibited high tumor specificity, strong in vivo stability, and significant uptake in FAP-expressing glioma tumors, further supporting its theranostic potential in neuro-oncology [24].